HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109. A total of 88 filers reported holding HARROW HEALTH INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $515 | +104.4% | 35,864 | +170.8% | 0.00% | – |
| Q2 2023 | $252 | -62.6% | 13,244 | -58.3% | 0.00% | – |
| Q1 2023 | $673 | +175.8% | 31,774 | +91.7% | 0.00% | – |
| Q4 2022 | $244 | -99.4% | 16,573 | +365.5% | 0.00% | – |
| Q3 2022 | $43,000 | +138.9% | 3,560 | +44.3% | 0.00% | – |
| Q2 2022 | $18,000 | +5.9% | 2,467 | 0.0% | 0.00% | – |
| Q1 2022 | $17,000 | -59.5% | 2,467 | -50.0% | 0.00% | – |
| Q4 2021 | $42,000 | -14.3% | 4,934 | -8.8% | 0.00% | – |
| Q3 2021 | $49,000 | +113.0% | 5,412 | +119.8% | 0.00% | – |
| Q2 2021 | $23,000 | -92.6% | 2,462 | -95.6% | 0.00% | – |
| Q3 2020 | $310,000 | +21.1% | 55,495 | +12.9% | 0.00% | – |
| Q2 2020 | $256,000 | +25500.0% | 49,136 | +12898.9% | 0.00% | – |
| Q1 2020 | $1,000 | -99.7% | 378 | -99.3% | 0.00% | – |
| Q3 2019 | $309,000 | – | 55,047 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,065,416 | $21,029,000 | 2.75% |
| Diametric Capital, LP | 252,774 | $1,734,000 | 1.38% |
| Birchview Capital, LP | 180,000 | $1,235,000 | 0.71% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 118,389 | $812,000 | 0.61% |
| Zebra Capital Management LLC | 58,062 | $398,000 | 0.50% |
| Precision Wealth Strategies, LLC | 62,739 | $430,000 | 0.47% |
| Sio Capital Management, LLC | 209,623 | $1,438,000 | 0.29% |
| Uniplan Investment Counsel, Inc. | 505,746 | $3,469,000 | 0.24% |
| CORRADO ADVISORS, LLC | 31,580 | $217,000 | 0.17% |
| BARD ASSOCIATES INC | 287,250 | $1,970,000 | 0.16% |